The Massachusetts Department of Public Health is reporting that more than 78,000 people in the state have recovered from COVID-19 infections.It is the first time that state health officials have released statewide recovery data in regard to the coronavirus.The DPH reported Wednesday that 78,108 of the 97,964 confirmed COVID-19 patients in Massachusetts have been released…
By Dan Boyd / Journal Capitol Bureau Chief Thursday, April 23rd, 2020 at 4:22pm SANTA FE — Top state health officials have announced seven additional deaths due to the COVID-19 outbreak, as the disease continues to ravage northwest New Mexico.The additional deaths bring the state’s death toll to 78. All seven of the deceased were…
Read the latest news on coronavirus in Delaware. More Info SMYRNA (April 16, 2020) – The Delaware Division of Public Health (DPH) is announcing six additional fatalities related to coronavirus disease 2019 (COVID-19) and is providing an update on the number of positive cases and recovered individuals. Due to system processing delays, today’s positive case total may…
KOB Web Staff Updated: April 16, 2020 05:29 PM Created: April 16, 2020 04:13 PM ALBUQUERQUE, N.M.- The New Mexico Department of Health (NMDOH) reported 8 additional COVID-19-related deaths in the state on Thursday. The latest deaths include: A female in her 80s from Bernalillo County. The individual had underlying medical conditions. The individual was…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f